Acute coronary syndrome (STEMI + NSTE-ACS) ⭐

acs · society: ACC/AHA/ACEP/NAEMSP/SCAI · high-yield

← back to Cardiology

Summary

Comprehensive 2025 multisociety guideline for management of acute coronary syndromes (STEMI, NSTEMI, unstable angina), replacing the 2013 STEMI, 2014 NSTE-ACS, 2015 PPCI focused update, and 2016 DAPT duration focused update guidelines. Major updates include preference for ticagrelor/prasugrel over clopidogrel, ticagrelor monotherapy after 1 month of DAPT in select patients, more aggressive LDL-C targets (<70 mg/dL, intensify if 55–<70), complete revascularization (preferably single-setting) in STEMI, routine radial access, intracoronary imaging for complex PCI, microaxial flow pump for selected AMI cardiogenic shock, and a more liberal transfusion threshold (Hb ~10 g/dL) in ACS with anemia.

Current guideline: 2025 ACC/AHA/ACEP/NAEMSP/SCAI ACS Guideline · download Anki sub-deck

Versions